|
ClinRx Renal Dosing & Kinetics Palm OS v. 5.1f Pocket PC v. 1.0
updated 3/14/2005
ClinRx is a creatinine clearance and kinetics
calculator for vancomycin and aminoglycoside dosing for adult and pediatric
patients. It includes "eDrugsRenal",
with renal dosing information for over 500 drugs, a phenytoin levels calculator
and a carboplatin/AUC dosing calculator. ClinRx includes a
graphical "Hartford Nomogram"
and "Urban-Craig
Nomogram" to assist in extended interval aminoglycoside
dosing. The calculations in ClinRx are based on the following equations: Cockcroft-Gault equation: CLcr (male) = IBW x (140 - Age) / 72Scr) CLcr (female)= as above multiplied by 0.85 Where: A = age in yrs; IBW = Ideal Body Weight in Kg IBW For males = 50 kg + 2.3 kg For each inch of height over 5 feet. IBW For females = 45.5 kg + 2.3 kg For each inch of height over 5 feet. Colkcroft-Gault Adjusted Wt: ClCr as in Colkcroft-Gault above but If the patient wt is 20% greater than IBW Then Adjusted Wt is used in the calculation. Adj.Wt.=((Actual Wt - IBW) x 0.4) + IBW MDRD (Levey Equation) From Modification of Diet in Renal Disease Study: CL = 170 x (Scr)-0.999 x (age, yr)-0.176 x 0.762 (if female) x 1.18 (if patient is black) x (BUN)-0.17 * (S. alb)0.318 per 1.73 m2
Jelliffe equation: ClCr (male) = (114 - 0.8 Age) / Scr per 1.73m2 female= as above multiplied by 0.9 Schwartz equation: CrCl = K x Ht/Scr / 1.73m2 Traub-Johnson equation: CrCl=0.28 x Ht x BSA/Scr adjusted to 1.73m2 The formulas used for the Vanco and Gent/Tobra kinetics calculations are derived from the Sarubbi/Hull method; Clinical Pharmacokinetics, Murphy, 2000, P37; Therapeutic Drug Monitoring, Schumacher, 1995 pp 274-277, and the Sawchuk-Zaske method.
(KE) gent/tobra = 0.2467(Clcr/100)+0.01 KE vanco = 0.001131 x CrCl+0.0029 (default) or KE vanco = 0.00083 x CrCl + 0.0044 (Matzke Formula) Half Life (T 1/2) = 0.693/KE Volume Distribution (VD) gent/tobra = 0.27L/DW (dosing wt = IBW or Adjusted Wt if obese) for pts < 65 and 0.3L/DW if 65 and over VD vanco = 0.65L/DW (dosing wt = actual wt) % left (PL) = e-(KE*T) where T = dosing interval Accumulation factor (AF) = 1/(1-PL) Peak (Pk) = AF x Dose/VD Trough (Tr) = Peak x PL Actual KE (KEa) = (ln(Pk/Tr)) / TA) (TA = Dosing Interval - time between levels) True Pk (Pka) = (reported Pk) / (e-(KEa x TB)) (TB = Time from End of infusion till blood drawn For level) True Tr (Tra) = (reported Tr) x (e-(KEa x TC)) (TC = Time from blood drawn till start of Next infusion) Actual VD (VDa) = (AF x Dose)/Pka For calculations with the kinetics equations, I use a maximum value for estimated ClCr of 130. If no weight is entered, I use a weight of 75kg For males And 60kg For females. The default CrCl carried forward into the kinetics equations is the Colcroft-Gault. The user may change this default to the Levey formula via the preferences screen. References: Cockcroft-Gault equation; Cockcroft D, Gault MD. Nephron, 16:31-41, 1976 Jelliffe equation; Jelliffe RW. Creatinine clearance: Bedside estimate. Ann Inter Med. 1973; 79:604
Jelliffe RW,
Estimation of creatinine clearance in patients with unstable renal function,
without a urine specimen. Levey Equation (MDRD); Levey AS, Bosch JP, Lewis JB, et al.; Ann Intern Med 1999;130(6):461-70 Schwartz equation; Ped Clin N. Amer, 1987, 34:571-90 Traub-Johnson equation; Am J Hosp Pharm 1980, 37:195-201 Sarubbi/Hull method; Clinical Pharmacokinetics, Murphy, 2000, P37 Sawchuk-Zaske method and the Matzke method; Therapeutic Drug Monitoring, Schumacher, 1995 pp 274-277 Hartford Nomogram; Nicolau DP, Antimicrob Agents Chemother. 1995 Mar; 39(3): 650-5 Urban-Craig Nomogram; Urban AW, Craig WA.; Curr Clin Top Infect Dis. 1997; 17: 236-55 Mosteller formula (Mosteller RD: Simplified Calculation of Body Surface Area. N Engl J Med 1987 Oct 22;317(17):1098
|
This section is invisible on purpose: aminoglycoside dosing obese
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||